Drugs / IPOL
last change Jul 2009 re-read 2 minutes ago

IPOL

Developed for
poliomyelitis
Investigated by
Sanofi

Trials 1 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00355121 Oct 2006 → Jun 2009 diphtheria, meningococcal meningitis, pertussis, poliomyelitis +1 Sanofi Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as IPOL “DAPTACEL® + IPOL on Day 0 and Menactra on Day 30” NCT00355121